The abuse of methamphetamine (MAP) and amphetamine (AMP) can produce psychosis resembling paranoid schizophrenia. 1) Similarly, the subchronic administration of MAP or AMP to experimental animals produces progressive and enduring augmentation of hyperlocomotion and stereotyped behavior. 2, 3) The precise neurochemical mechanism underlying this phenomenon, referred to as behavioral sensitization or reverse tolerance, is not completely understood.
We have previously studied the pharmacokinetic alteration of MAP in the brain following the chronic administration of MAP and reported the significant increase in the [ 11 C]MAP uptake of the MAP-sensitized mouse brain 4) and in the [ 14 C]MAP uptake of the MAP-sensitized rat brain. 5) In addition, we reported that the maximum accumulation level of [ 11 C]MAP in the MAP-sensitized dog brain was 1.4 times higher than that in the control. 6) On the other hand, cocaine is also known to produce behavioral sensitization, and Nayak et al. 7) reported that the brain/plasma ratio of cocaine in chronically treated animals was somewhat higher than that of acutely treated animals as well as the cocaine distribution was altered in the chronic group, suggesting that the uptake of cocaine in the brain is influenced by the alteration of the cocaine distribution in the chronically treated animals. However, since we could not find any reports on the organ distribution of MAP in the MAP-sensitized animals, the influence of the organ distribution of MAP on the high accumulation of MAP in the MAP-sensitized rat brain is unknown. Therefore, a clarification of the relationship between the accumulation in the MAP-sensitized rat brain and the altered distribution of MAP is needed.
Since the gas chromatography/mass spectrometry (GC/ MS) technique, which provides a high sensitivity and high resolution, measures a very small amount of only the nonmetabolized drug, it is clear that the data obtained by this method is much more reliable than those obtained by experiment using radioisotopes. Therefore, the purpose of the present study is to elucidate the MAP distribution in the MAPsensitized rat using GC/MS. 
Brain and Heart Specific Alteration of Methamphetamine (MAP) Distribution in MAP-Sensitized Rat

Animal Experiments Preparation of MAP Sensitization Model
The rats were intraperitoneally injected with 4 mg/ kg of MAP once daily for 14 consecutive days. The control rats received an equal volume of saline for the same length of time. After 7 consecutive days of withdrawal in each model, stereotyped behavior was scored using a stereotypy rating scale of Creese and Iversen, 8) after the administration of the drug, and we confirmed the expression of behavioral sensitization in MAP sensitization model. We used these animals as the MAP sensitization model and control model to the experiment. We used 3-6 rats in each model.
MAP Distribution in Brain and the Other Organs
The cannula (SP31) for injection of the MAP solution and for the collection of blood was inserted in the femoral vein and in the femoral artery, respectively, under ether anesthesia. After recovery from anesthesia, a bolus of 4 mg/kg of MAP was rapidly injected into the femoral vein. After injection, blood was collected in heparinized tubes at 1 and 10 min, and then rats were decapitated at the same time. The brain, heart, liver, kidney, femoral muscle and abdominal muscle were immediately removed and then frozen at Ϫ80°C until measurements of the MAP by GC/MS. The reason why we selected 1 and 10 min is described below. Because MAP was distributed to the organs very rapidly, we decided to examine at 1 min after injection. Mizugaki 4) examined the MAP distribution to the mice brain at 15 min after intravenous injection and Numachi 5) also examined the MAP distribution in the rat brain at 30 min after intravenous injection, which researchers reported the significant increase in the MAP uptake of the MAP-sensitized animals. So we decided to select 10 min, the faster time than 15 or 30 min for the examination on the high accumulation of MAP in the MAP-sensitized rat brain and on the distribution of MAP in the organs.
Methamphetamine Extraction Procedure Two brain areas that included the frontal cortex and striatum were analyzed according to the method of Glowinski and Iversen. 9) Each sample of tissue was weighed just before the MAP extraction procedure. After adding 100 ng of MAP-d 3 as an internal standard in each sample tube that included the tissue sample, the samples were homogenated with 1 ml of methanol using homogenizer. The homogenates were centrifuged at 12000ϫg for 5 min. The supernatants were decanted in other tubes filled with 10 ml of 0.1 M phosphate buffer (pH 6.0). After adding 1 ml of methanol to pellet, the above procedure was repeated.
To prepare for the Bond Elute Certify, 2 ml of methanol and 2 ml of 0.1 M phosphate buffer (pH 6.0) were sequentially passed through a column. The supernatant was applied to the column and slowly dropped under reduced pressure. The column was rinsed with 1 ml of 1.0 M acetic acid and dried under reduced pressure for 5 min. Six milliliters of methanol was then passed through the column under reduced pressure for 2 min. MAP was eluted with 2 ml of 2% (v/v) ammonium hydroxide in ethyl acetate, and the eluent was removed under a slow flow of nitrogen at 30-40°C. HFB for derivatization was reacted with the extracted methamphetamine at 80°C for 60 min. After removing the unreacted HFB using a nitrogen stream, 50 ml of ethyl acetate was added for the gas chromatography/selected ion monitoring (GC/SIM) measurements.
Measurement of MAP Using GC/SIM Quantification was performed using GC/SIM in the positive electron impact ionization mode. The GC/MS system was an HP5890 gas chromatography (Hewlett-Packard, USA) and DX303 mass spectrometer (JEOL, Japan). The column was a 25 mϫ0.25 mm I.D. fused silica capillary cross-linked column with (5%-phenyl)-methylpolysiloxane (DB-5; J & W Scientific, Folsom, CA, U.S.A). The oven temperature was programmed from 100-180°C (8°C/min), and the injector was at 320°C. The carrier gas was helium. The ionization energy and accelerating voltage were 70 eV and 3 kV, respectively. The ions at m/z 254 for MAP and at m/z 257 for MAPd 3 were monitored with a dynamic resolution of 1000.
Calculation and Statistical Analysis The MAP distribution in each tissue was represented as the differential absorption ratio (DAR). DAR was calculated as (observed tissue amount/tissue weight)/(injected dose/body weight). The statistical analysis were performed using StatView software (Abacus Concepts Inc., Berkeley, CA, U.S.A.). Mann-Whitney's U-test was used to analyze the findings. Differences were considered significant at pϽ0.05.
RESULTS
In the present study, to elucidate the MAP distribution in the MAP-sensitized rat, the concentrations of MAP in the frontal cortex, striatum, heart, liver, kidney, femoral muscle, abdominal muscle and blood were measured using GC/MS and DAR of the MAP-sensitized rat which was then compared to that of the control rat. Figure 1a shows the DAR of MAP in the frontal cortex and striatum. In the frontal cortex, the DAR of the MAP-sensitized rat at 10 min after injection was significantly higher than that of the control rat. In the striatum, the DAR of the MAP-sensitized rat at 10 min after injection was significantly higher than that of the control rat. Therefore, we reconfirmed our previous reports of the highaccumulation of MAP in the MAP-sensitized animal brain in this study.
Under the condition of showing the high-accumulation of MAP in the MAP-sensitized rat brain, Fig. 1b and 1c show the DAR of MAP in the heart, liver, kidney, femoral muscle, abdominal muscle and blood. The DAR of the MAP-sensitized rat in the heart at 10 min was significantly higher than that of the control rat, however, no significant differences in the DAR between the MAP-sensitized rat and control rat in the liver, kidney (Fig. 1b) , femoral muscle, abdominal muscle and blood (Fig. 1c) were observed at 1 and 10 min.
DISCUSSION
In the frontal cortex and striatum, the DAR of the MAPsensitized rat at 10 min after injection was significantly higher than that of the control rat. Our previous reports measured the radioactivity of 11 C in the MAP-sensitized mouse brain 4) or dog brain, 6) which possibility included the radioactivity of the metabolites of [ 11 C]MAP in the brain. On the other hand, this study measured only the unchanged MAP by GC/MS, suggesting that the result in this study strongly agreed with our previous reports. At the corresponding 10 min after injection, a significant higher distribution was observed in only the heart. The DAR at 10 min was lower than that at 1 min in the heart between both the control rats and MAP-sensitized rats, suggesting that the delayed efflux of MAP from the heart to blood occurred in the MAP-sensitized rat. Namely, a longer exposure of the MAP to the heart in MAP-sensitized rat ought to induce some harmful cardiac disorders. It has been reported that cardiac muscle lesions are associated with the chronic administration of MAP in rats, 10) that cardiomyopathy was associated with the AMP administration in humans 11) and that MAP directly induced cellular hypertrophy and might lead to cardiac functional disorder. 12) These studies on cardiac disorders were reported, however, there is no report on the comparative study of the MAP concentration in the heart, that is, the result in the present study is the first finding. Therefore, it is possible to consider that the delayed efflux of MAP from the heart to blood leads to the cardiac toxicity.
It has been reported that the mean arterial blood pressure increased in the MAP-sensitized rat, 13) and the albumin permeability from the tight junction of the blood-brain barrier (BBB) correlated with the increased blood pressure, 14) suggesting that the MAP distribution in the brain was easily influenced by the increased arterial blood pressure. However, the MAP distribution in the other organs including the liver, kidney and muscles did not increase at 10 min, which is considered that there is not a direct correlation between the highaccumulation of MAP in the MAP-sensitized rat brain and the arterial blood pressure in the present study. Also the DAR of the frontal cortex and striatum at 1 min was about 3.5-5 times higher than that of the blood at the same time, suggesting that the MAP distribution into the brain depends on the cerebral blood flow. It has been reported that the DAR of [
123 I]-N-isopropyl-iodoamphetamine for the measurement of the cerebral blood flow was not changed when the high-accumulating MAP in the MAP-sensitized rat brain was measured using [ 14 C]MAP. 5) Therefore, it is also difficult to consider the direct effect of increased cerebral blood flow due to the delayed efflux of MAP from the heart to blood. As already mentioned, it is considered that the delayed efflux of MAP from the MAP-sensitized rat heart dose not correlate with the high-accumulation of MAP in the MAP-sensitized rat brain.
We have another new finding in the present study, namely we describe the comparative MAP distribution at 1 min after injection, a time that has not been examined in other studies. The MAP distribution at 1 min after injection reflects only the influx process from the blood to brain or blood to heart. There was no difference in the MAP distribution at 1 min between the control rat brain and MAP-sensitized rat brain, suggesting that MAP sensitization did not influence the influx process of the MAP distribution. On the contrary, the MAP distribution at 10 min after injection reflects both the influx process and the efflux process. In addition, in spite of the fast excretion of MAP in the blood in MAP-sensitized rat compared with the control rat at 10 min (Fig. 1c) , the highaccumulation of MAP in the MAP-sensitized rat brain and heart was occurred at 10 min. So, it is interpreted that the efflux process of MAP from the brain to blood or heart to blood is slow due to MAP sensitization. This consideration has two possibilities, that is, the release of MAP from brain cells is slow or the transport of MAP from brain to blood through the BBB is slow. In the heart, it is also interpreted that the release of MAP from the cardiac cells is slow. Consequently, it is possible to consider that some biochemical alterations or changes in the transport protein on the MAP distribution occur in the MAP-sensitized rat brain and heart.
Kitaichi measured the extracellular MAP concentration in the rat brain using microdialysis from 0.5 h to 3.5 h, and reported that MAP concentration in MAP sensitized rat was increased than that in control rat. 15) In the present study, we reported that the high accumulation of MAP in the MAP-sensitized rat brain was occurred at 10 min. So we could consider that the high accumulation of MAP in the MAP-sensitized rat brain was maintained until a steady state of MAP distribution.
In conclusion, it was clear that the brain and heart specific alteration of the MAP distribution occurred in the MAP sen- sitization. It is suggested that the high accumulation of MAP in the MAP-sensitized rat brain may be related to the expression of behavioral sensitization and that the delayed efflux of MAP from the MAP-sensitized rat heart may be connected to the cardiac toxicity.
